Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma

BACKGROUND: High tumor mutation burden (TMB) has gradually become a sensitive biomarker for predicting the response to immunotherapy in many cancers, including lung, bladder and head and neck cancers. However, whether high TMB predicts the response to immunotherapy and prognosis in pancreatic ductal...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Cell Int
Glavni autori: Tang, Rong, Liu, Xiaomeng, Wang, Wei, Hua, Jie, Xu, Jin, Liang, Chen, Meng, Qingcai, Liu, Jiang, Zhang, Bo, Yu, Xianjun, Shi, Si
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Primary Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8028808/
https://ncbi.nlm.nih.gov/pubmed/33827590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01900-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items